Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Neovasc Shares Climb 80% Upon FDA Premarket Approval Filing for Refractory Angina Device

Shares of specialty cardiovascular medical device company Neovasc Inc. opened more than 100% higher after the firm reported that it submitted a Premarket Approval application to the FDA for its Neovasc Reducer device for use in the treatment of refractory angina. This...
Streetwise Reports | January 3, 2020 |

The Medical Device Co. That’s on the Cutting-Edge of Advancing Heart Disease Treatment

Back in early September , we introduced our Stockhouse audience to a unique play in the emerging medical tech space – Neovasc Inc. ( TSX: NVCN , OTCQB: NVCN , Forum ). The company develops, manufactures, and markets products for the rapidly growing cardiovascular marke...
Dave Jackson | November 29, 2021 |

Making Moves in a Rising Yet Uncertain Gold Market

Even with an ongoing global pandemic, gold has remained hot . For enterprising investors and exploration companies, what’s the current best play? At the start of the year, rising prices and strong, sustained fundamentals led experts to be bullish on th...
Omri Wallach | April 29, 2020 |

3D printing is a manufacturing game-changer

Calling all carnivores: ever thought about getting a meat printer? Of hand-crafting delectable beef steaks at home from plant proteins, that have the same texture, appearance and flavor as real meat, only without the distasteful killing part? 3D-printed steaks and chicken ...
Richard (Rick) Mills | November 15, 2019 |

Living in a virus-controlled world

As the coronavirus pandemic continues to infect populations, though in some countries it is slowing, talk has shifted to re-opening economies, and to manufacturing a vaccine that drug companies hope will not only work, but can be distributed at large enough doses to provide ...
Richard (Rick) Mills | April 24, 2020 |

Market News Report: March 16, 2020 - March 20, 2020

The scheduled economic data releases were much less important than monetary policy updates or governments’ interventions news last week. Shocking Fed’s Interest Rates cut and the QE announcement on Sunday is leading to another risk-on assets&Clo...
Paul Rejczak | March 16, 2020 |

Market News Report: December 23 – December 27, 2019

Last week the markets went “risk on” following positive economic data releases. Will the coming holiday week bring some interesting news events? Let’s take a look at the details. The week behind Last week’s Monday&Cl...
Paul Rejczak | December 27, 2019 |

Market News Report: March 23, 2020 - March 27, 2020

It has happened again. The scheduled economic data releases were much less important than virus crisis news last week. However, the coming releases are starting to show a severe economic downturn. So, markets will likely pay more attention to the economic data releases in the ...
Paul Rejczak | March 23, 2020 |

Immunotherapy Firm Releases Data Showing Treatment Potential Against Sepsis

Recently presented results from Enlivex Therapeutics' Phase 1b study in sepsis and their implications are reviewed in an H.C. Wainwright & Co. report. In a June 1 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that Enlivex Therapeutics Ltd.'s ...
Streetwise Reports | June 4, 2020 |

PROFIT! A NEW Stockhouse Vodcast Series. Eps. 2

Get to know capital market moguls, mavens and management teams in a more relaxed setting. Episodes open with fun, rapid-fire questions, setting the tone for a more informal one-on-one session. You won’t want to miss our weekly releases featuring thought ...
Cindy Broad | January 24, 2020 |
1 2 3 4 5 6 7 8 9 10 ...
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested